Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study-Reference-Cited by-同舟云学术

Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study

Published:2023-07 Issue:1 Volume:87 Page:46-53
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Puerta-Alcalde Pedro,Monzó-Gallo Patricia,Aguilar-Guisado Manuela,Ramos Juan Carlos,Laporte-Amargós Júlia,Machado Marina,Martin-Davila Pilar,Franch-Sarto Mireia,Sánchez-Romero Isabel,Badiola Jon,Gómez Lucia,Ruiz-Camps Isabel,Yáñez Lucrecia,Vázquez Lourdes,Chumbita Mariana,Marco Francesc,Soriano Alex,González Pedro,Fernández-Cruz Ana,Batlle Montserrat,Fortún Jesús,Guinea Jesús,Gudiol Carlota,García Julio,Ruiz Pérez de Pipaón Maite,Alastruey-Izquierdo Ana,Garcia-Vidal Carolina

Funder

European Commission

Instituto de Salud Carlos III

Gilead Sciences

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference36 articles.

1. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole;Marr;J Infect Dis,2000

2. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia;Cornely;N Engl J Med,2007

3. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease;Ullmann;N Engl J Med,2007